MENU
SRRK
AS OF
Feb 4, 04:41 PM (EDT)
Price
$47.45
Change
-$0.50 (-1.04%)
Capitalization
4.89B
34 days until earnings call
Intraday BUY SELL Signals

SRRK Stock Scholar Rock Holding (SRRK, $47.95) Moving Average Convergence Divergence (MACD) Histogram turned positive on February 3, 2026

A.I.dvisor
at Tickeron.com
Loading...
SRRK - Scholar Rock Holding Corp
MACD signal
Bullish Trend
Odds of UP Trend
Tickeron
MACD signal
Price: $47.95
Daily change: +$1.34 (+2.87%)
Daily volume: 1M
Capitalization: $4.9B
Industry: Biotechnology

This is a Bullish indicator signaling SRRK's price could rise from here. Traders may explore going long the stock or buying call options. A.I. dvisor identified 46 similar cases where SRRK's MACD histogram became positive, and of them led to successful outcomes. Odds of Success:

SRRK in upward trend: price rose above 50-day moving average on January 29, 2026

SRRK moved above its 50-day moving average on January 29, 2026 date and that indicates a change from a downward trend to an upward trend. In of 40 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 63 cases where SRRK's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on February 02, 2026. You may want to consider a long position or call options on SRRK as a result. In of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for SRRK just turned positive on February 03, 2026. Looking at past instances where SRRK's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SRRK advanced for three days, in of 286 cases, the price rose further within the following month. The odds of a continued upward trend are .

SRRK may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SRRK declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for SRRK entered a downward trend on January 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SRRK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (19.960) is normal, around the industry mean (27.519). P/E Ratio (0.000) is within average values for comparable stocks, (51.491). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.893). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (331.843).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SRRK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
SRRK
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. SRRK showed earnings on November 14, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a r&d company in biotechnology

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
301 Binney Street
Phone
+1 857 259-3860
Employees
150
Web
https://www.scholarrock.com